Pharmacology, Part II (2011/065)

Receive a continuing education certificate immediately by visiting to take the test, complete the evaluation, and pay processing fees online.


This continuing education issue has been approved by the American College of Nurse-Midwives (ACNM) for 2.0 continuing education units (CEUs) inclusive of 2.0 pharmacology CEUs (20 contact hours inclusive of 20 pharmacology contact hours). All continuing education forms must be received by December 31, 2013.

ACNM is an approved provider of CEUs for certified nurse-midwives/certified midwives (CNMs/CMs). ACNM CEUs are accepted for the American Midwifery Certification Board (AMCB) Certificate Maintenance Program (CMP) and for National Certification Corporation (NCC) certification maintenance. Other professional groups may recognize ACNM CEUs as well. Health care providers who are not CNMs/CMs should check with their certifying and licensing agencies.


  • 1Complete this form.
  • 2Enclose a check or money order made payable to ACNM or Visa or MasterCard information and mail or fax to:American College of Nurse-MidwivesP.O. Box 759147Baltimore, MD 21275-9147Fax: 240-485-1818
  • 3Participants will receive a CEU certificate in the mail. Please allow 4 weeks for processing. The date on the CEU certificate will be the day remuneration and the completed form are received.
  • 4There is a rush fee of $20.00 for immediate processing. All rush orders must be faxed with Visa or MasterCard information to 240-485-1818. Rush orders will be processed within 3 business days after credit card has been charged.

inline image


After reading the articles, fill in the answers to the test questions on the reverse side of this page in the space provided below.


inline image


After completion of this continuing education issue, the participant will:

  • 1Describe regulatory requirements relative to prescriptive authority for certified nurse-midwives and certified midwives in the United States.
  • 2Identify the precautions, preparation, and procedure for use of nitrous oxide for labor analgesia.
  • 3Compare the US Medical Eligibility Criteria for Contraceptive Use (MEC) and World Health Organization MEC.


Select the one best answer for each of the multiple-choice questions below.

  • 1How many states grant certified nurse-midwives the authority to write prescriptions? (Osborne)
    • a. 42
    • b. 48
    • c. 50
  • 2Nitrous oxide is eliminated from the body through the: (Rooks)
    • a. lungs.
    • b. skin.
    • c. urine.
  • 3Which of the following are used to monitor for magnesium sulfate toxicity? (Hunter & Gibbins)
    • a. Blood pressure and visual field testing
    • b. Heart rate and mental status examination
    • c. Respiratory rate and patellar reflex
  • 4Treatment options for pregnant women with bacterial vaginosis include: (Manns-James)
    • a. azithromycin.
    • b. ceftriaxone.
    • c. metronidazole.
  • 5The primary plant-based omega-3 fatty acid is: (Dennehy)
    • a. alpha linolenic acid (ALA).
    • b. docosahexaenoic acid (DHA).
    • c. eicosapentaenoic acid (EPA).
  • 6The greatest benefit of a single course of antenatal corticosteroids for the fetus at increased risk of preterm birth is the reduction of: (Riley)
    • a. preterm birth.
    • b. respiratory distress.
    • c. stillbirth.
  • 7Which of the following describes the use of progestin-only contraceptives in the first month postpartum according to the US Medical Eligibility Criteria for Contraceptive Use? (Jacobson & Murphy)
    • a. The risks of these methods on breastfeeding generally outweigh the risk of unplanned pregnancy.
    • b. The risk of unplanned pregnancy generally outweighs the risks of these methods on breastfeeding.
    • c. There are no concerns about use of this method and effects on breastfeeding.
  • 8Empiric treatment of sexual partners of patients diagnosed with a sexually transmitted infection without evaluation of the partner by a health care provider is known as: (FitzMaurice et al)
    • a. accelerated partner therapy.
    • b. patient referral.
    • c. patient-delivered partner therapy.
  • 9The most commonly reported side effect of oral bisphosphonate therapy is: (Schuiling et al)
    • a. esophageal and gastric irritation.
    • b. musculoskeletal pain.
    • c. weight gain due to increased appetite.
  • 10Combined oral contraceptives decrease the risk of: (King)
    • a. breast cancer.
    • b. endometrial cancer.
    • c. liver cancer.

Receive a continuing education certificate immediately by visiting to take the test, complete the evaluation, and pay processing fees online.